Unilateral axillary lymphadenopathy (differential)
Updates to Article Attributes
Body
was changed:
Unilateral axillary lymphadenopathy while being more concerning than bilateral axillary lymphadenopathy can still arise from a variety of benign, as well as malignant, causes.
Benign
- mastitis
- other regional infective causes
- tuberculosis
- ipsilateral arm infection, e.g. cellulitis
- silicone induced granulomatous adenitis
- post-vaccination: described for both influenza and COVID-19 vaccines, usually self-limiting 4,5
Malignant
- metastasis from breast malignancy
- metastasis from non-breast malignancies
- melanoma: a relatively common non-breast primary malignancy to present with axillary lymphadenopathy
- primary malignancy in ipsilateral arm
- lymphoma: can occasionally be unilateral
See also
-<p><strong>Unilateral axillary lymphadenopathy</strong> while being more concerning than <a title="Bilateral axillary lymphadenopathy (differential)" href="/articles/bilateral-axillary-lymphadenopathy-differential">bilateral axillary lymphadenopathy</a> can still arise from a variety of benign, as well as malignant, causes.</p><h5>Benign</h5><ul>- +<p><strong>Unilateral axillary lymphadenopathy</strong> while being more concerning than <a href="/articles/bilateral-axillary-lymphadenopathy-differential">bilateral axillary lymphadenopathy</a> can still arise from a variety of benign, as well as malignant, causes.</p><h5>Benign</h5><ul>
-<li>ipsilateral arm infection, e.g. <a title="Cellulitis" href="/articles/cellulitis">cellulitis</a>- +<li>ipsilateral arm infection, e.g. <a href="/articles/cellulitis">cellulitis</a>
- +<li>
- +<a href="/articles/vaccination">post-vaccination</a>: described for both <a href="/articles/influenza">influenza</a> and <a href="/articles/covid-19-4">COVID-19</a> vaccines, usually self-limiting <sup>4,5</sup>
- +</li>
References changed:
- 4. Shirone N, Shinkai T, Yamane T, Uto F, Yoshimura H, Tamai H, Imai T, Inoue M, Kitano S, Kichikawa K, Hasegawa M. Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination. (2012) Annals of nuclear medicine. 26 (3): 248-52. <a href="https://doi.org/10.1007/s12149-011-0568-x">doi:10.1007/s12149-011-0568-x</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/22271546">Pubmed</a> <span class="ref_v4"></span>
- 5. Mehta N, Sales RM, Babagbemi K, Levy AD, McGrath AL, Drotman M, Dodelzon K. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine. (2021) Clinical imaging. 75: 12-15. <a href="https://doi.org/10.1016/j.clinimag.2021.01.016">doi:10.1016/j.clinimag.2021.01.016</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/33486146">Pubmed</a> <span class="ref_v4"></span>